Membranous nephropathy in a patient with ankylosing spondylitis: A case report. 2017

Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
Division of Nephrology, Huashan Hospital Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, China.

BACKGROUND Renal complications in ankylosing spondylitis (AS) were rarely observed, and proteinuria associated with AS can be seen often due to amyloidosis in this kind of complications, while membranous nephropathy (MN) is seldom considered. This article reports a case of coexistence of AS and MN, to provide the exact relationship of these 2 entities and recognized some causes of renal involvement in AS. METHODS A 44-year-old female presented with pain of the left leg for 4 years and pedal edema for 2 weeks. METHODS AS was diagnosed according to the patient's clinical manifestation and sacroiliitis observed on computed tomography (CT) scan. Nephrotic syndrome was found and MN was diagnosed according to kidney biopsy in which thickened capillary loops were observed with light microscopy, granular deposits of IgG along the capillary wall were observed using immunofluorescence staining, and subepithelial electron-dense deposits were observed with electron microscopy. No other secondary causes of MN were found on extensive investigations. METHODS Given the diagnoses, the patient received nonimmunosuppressive therapy for MN and adalimumab for AS. RESULTS The patient got pain relief, as well as urinary protein reduction. CONCLUSIONS This case suggested a secondary MN in association with AS and the relationship between these 2 diseases needed more concern and further illumination.

UI MeSH Term Description Entries
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068579 Celecoxib A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN. 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,Celebrex,SC 58635,SC-58635,SC58635
D000068879 Adalimumab A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. Adalimumab-adbm,Adalimumab-atto,Amjevita,Cyltezo,D2E7 Antibody,Humira,Antibody, D2E7
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013167 Spondylitis, Ankylosing A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions. Ankylosing Spondylitis,Bechterew Disease,Marie-Struempell Disease,Rheumatoid Spondylitis,Spondylarthritis Ankylopoietica,Ankylosing Spondylarthritis,Ankylosing Spondyloarthritis,Bechterew's Disease,Spondylitis Ankylopoietica,Spondyloarthritis Ankylopoietica,Ankylosing Spondylarthritides,Ankylosing Spondyloarthritides,Bechterews Disease,Marie Struempell Disease,Spondylarthritides, Ankylosing,Spondylarthritis, Ankylosing,Spondylitis, Rheumatoid,Spondyloarthritides, Ankylosing,Spondyloarthritis, Ankylosing
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015433 Glomerulonephritis, Membranous A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane. Heymann Nephritis,Membranous Glomerulopathy,Nephropathy, Membranous,Extramembranous Glomerulopathy,Idiopathic Membranous Glomerulonephritis,Idiopathic Membranous Nephropathy,Membranous Glomerulonephropathy,Membranous Nephropathy,Glomerulonephritides, Idiopathic Membranous,Glomerulonephritides, Membranous,Glomerulonephritis, Idiopathic Membranous,Glomerulonephropathy, Membranous,Glomerulopathy, Extramembranous,Glomerulopathy, Membranous,Idiopathic Membranous Glomerulonephritides,Membranous Glomerulonephritides,Membranous Glomerulonephritides, Idiopathic,Membranous Glomerulonephritis,Membranous Glomerulonephritis, Idiopathic,Membranous Nephropathy, Idiopathic,Nephritis, Heymann,Nephropathy, Idiopathic Membranous
D052246 Cyclooxygenase 2 Inhibitors A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. COX-2 Inhibitor,COX2 Inhibitor,Coxib,Cyclooxygenase 2 Inhibitor,Cyclooxygenase-2 Inhibitor,COX-2 Inhibitors,COX2 Inhibitors,Coxibs,Cyclooxygenase-2 Inhibitors,2 Inhibitor, Cyclooxygenase,COX 2 Inhibitor,COX 2 Inhibitors,Inhibitor, COX-2,Inhibitor, COX2,Inhibitor, Cyclooxygenase 2,Inhibitor, Cyclooxygenase-2,Inhibitors, COX-2,Inhibitors, COX2,Inhibitors, Cyclooxygenase 2,Inhibitors, Cyclooxygenase-2

Related Publications

Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
May 2020, Medicine,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
January 2002, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
January 1981, Nephron,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
January 1985, Nephron,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
June 2023, Turkish journal of physical medicine and rehabilitation,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
March 2021, World journal of clinical cases,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
December 2009, Clinical and experimental nephrology,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
January 2013, Turkiye parazitolojii dergisi,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
December 2010, Annals of physical and rehabilitation medicine,
Ruiying Chen, and Fang Li, and Qionghong Xie, and Jun Xue, and Lingyun Lai, and Shaojun Liu, and Liyin Zhang, and Chuanming Hao
January 2019, Medicine,
Copied contents to your clipboard!